Lindbrook Capital, LLC Aerie Pharmaceuticals Inc Transaction History

Lindbrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$6.37 - $15.23 $101 - $243	-16 Reduced 50.0%	16 $0
Q2 2022 Aug 01, 2022	BUY	$4.95 - $9.16 $158 - $293	32 New	32 $0
Q4 2021 Jan 18, 2022	SELL	$7.02 - $13.33 $2,716 - $5,158	-387 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$11.32 - $16.63 $1,233 - $1,812	-109 Reduced 21.98%	387 $4,000
Q4 2020 Jan 27, 2021	BUY	$9.12 - $14.49 $2,270 - $3,608	249 Added 100.81%	496 $7,000
Q3 2020 Nov 03, 2020	BUY	$10.46 - $14.46 $2,583 - $3,571	247 New	247 $3,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.